ENTA Historical PE Ratio image   This ENTA PE ratio history page last updated 3/12/2024
ENTA PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
2/7/2024
12.26-1.58-6.56NA
Q4 2023
11/20/2023
8.94-1.33-6.37NA
Q3 2023
8/7/2023
19.34-1.86-6.31NA
Q2 2023
5/8/2023
34.33-1.79-5.98NA
Q1 2023
2/7/2023
54.59-1.39-5.82NA
Q4 2022
11/21/2022
46.40-1.27-5.91NA
Q3 2022
8/8/2022
71.27-1.53-5.86NA
Q2 2022
5/9/2022
52.93-1.63-5.52NA
Q1 2022
2/8/2022
61.18-1.48-4.98NA
Q4 2021
11/22/2021
75.18-1.22-3.91NA
Q3 2021
8/5/2021
46.25-1.19-4.15NA
Q2 2021
5/6/2021
51.00-1.09-3.67NA
Q1 2021
2/8/2021
54.95-0.41-2.88NA
Q4 2020
11/23/2020
43.67-1.46-1.82NA
Q3 2020
8/4/2020
47.69-0.710.08>500
Q2 2020
5/6/2020
51.67-0.301.1246.1
Q1 2020
2/6/2020
55.620.651.6234.3
Q4 2019
11/21/2019
63.510.442.2228.6
Q3 2019
8/6/2019
70.830.333.0823.0
Q2 2019
5/7/2019
87.590.203.7223.5
Q1 2019
2/6/2019
83.801.254.1320.3
Q4 2018
11/26/2018
81.911.303.6622.4
Q3 2018
8/7/2018
91.760.974.2221.7
Q2 2018
5/8/2018
105.570.612.8137.6
Q1 2018
2/7/2018
89.060.781.9246.4
Q4 2017
11/20/2017
49.711.860.8856.5
Q3 2017
8/7/2017
38.50-0.44-1.07NA
Q2 2017
5/8/2017
30.81-0.28-0.69NA
Q1 2017
2/8/2017
31.17-0.26-0.50NA
Q4 2016
11/21/2016
30.07-0.091.1226.8
Q3 2016
8/8/2016
21.71-0.061.5014.5
Q2 2016
5/9/2016
25.45-0.091.6915.1
Q1 2016
2/8/2016
21.521.363.276.6
Q4 2015
11/23/2015
31.880.294.097.8
Q3 2015
8/6/2015
46.430.133.5313.2
Q2 2015
5/7/2015
33.721.496.015.6
Q1 2015
2/5/2015
35.172.184.248.3
Q4 2014
11/24/2014
45.21-0.271.7625.7
Q3 2014
8/11/2014
38.472.611.7821.6
Q2 2014
5/12/2014
34.78-0.28-1.06NA
Q1 2014
2/13/2014
38.18-0.30-3.06NA
Q4 2013
11/25/2013
24.84-0.25NANA
Q3 2013
8/12/2013
18.87-0.23NANA
Q2 2013
5/8/2013
20.07-2.28NANA
ENTA Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
2/7/2024
12.26-1.58-6.32NA
Q4 2023
11/20/2023
8.94-1.33-5.32NA
Q3 2023
8/7/2023
19.34-1.86-7.44NA
Q2 2023
5/8/2023
34.33-1.79-7.16NA
Q1 2023
2/7/2023
54.59-1.39-5.56NA
Q4 2022
11/21/2022
46.40-1.27-5.08NA
Q3 2022
8/8/2022
71.27-1.53-6.12NA
Q2 2022
5/9/2022
52.93-1.63-6.52NA
Q1 2022
2/8/2022
61.18-1.48-5.92NA
Q4 2021
11/22/2021
75.18-1.22-4.88NA
Q3 2021
8/5/2021
46.25-1.19-4.76NA
Q2 2021
5/6/2021
51.00-1.09-4.36NA
Q1 2021
2/8/2021
54.95-0.41-1.64NA
Q4 2020
11/23/2020
43.67-1.46-5.84NA
Q3 2020
8/4/2020
47.69-0.71-2.84NA
Q2 2020
5/6/2020
51.67-0.30-1.20NA
Q1 2020
2/6/2020
55.620.652.6021.4
Q4 2019
11/21/2019
63.510.441.7636.1
Q3 2019
8/6/2019
70.830.331.3253.7
Q2 2019
5/7/2019
87.590.200.80109.5
Q1 2019
2/6/2019
83.801.255.0016.8
Q4 2018
11/26/2018
81.911.305.2015.8
Q3 2018
8/7/2018
91.760.973.8823.6
Q2 2018
5/8/2018
105.570.612.4443.3
Q1 2018
2/7/2018
89.060.783.1228.5
Q4 2017
11/20/2017
49.711.867.446.7
Q3 2017
8/7/2017
38.50-0.44-1.76NA
Q2 2017
5/8/2017
30.81-0.28-1.12NA
Q1 2017
2/8/2017
31.17-0.26-1.04NA
Q4 2016
11/21/2016
30.07-0.09-0.36NA
Q3 2016
8/8/2016
21.71-0.06-0.24NA
Q2 2016
5/9/2016
25.45-0.09-0.36NA
Q1 2016
2/8/2016
21.521.365.444.0
Q4 2015
11/23/2015
31.880.291.1627.5
Q3 2015
8/6/2015
46.430.130.5289.3
Q2 2015
5/7/2015
33.721.495.965.7
Q1 2015
2/5/2015
35.172.188.724.0
Q4 2014
11/24/2014
45.21-0.27-1.08NA
Q3 2014
8/11/2014
38.472.6110.443.7
Q2 2014
5/12/2014
34.78-0.28-1.12NA
Q1 2014
2/13/2014
38.18-0.30-1.20NA
Q4 2013
11/25/2013
24.84-0.25-1.00NA
Q3 2013
8/12/2013
18.87-0.23-0.92NA
Q2 2013
5/8/2013
20.07-2.28-9.12NA
Quotes delayed 20 minutes

Email EnvelopeFree ENTA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Enanta Pharma (ENTA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ENVB PE Ratio History
ENZ PE Ratio History
EOLS PE Ratio History
EPZM PE Ratio History
EQ PE Ratio History
ERAS PE Ratio History
ERNA PE Ratio History
ESPR PE Ratio History
ETNB PE Ratio History
ETON PE Ratio History
On this page we presented the ENTA PE Ratio History information for Enanta Pharma' stock. The average ENTA PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 30.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ENTA PE ratio history based on this TTM earnings result method is 24.1. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ENTA PE ratio history result, against the recent PE: when this page was posted on 3/11/2024, the most recent closing price for ENTA had been 15.08, and the most recent quarterly earnings result, annualized, was 2.6. Meanwhile, the most recent TTM earnings summed to 0.08. From these numbers, we calculate the recent ENTA PE on 3/11/2024 based on annualized quarterly EPS was 5.8. Based on ENTA's history, that recent PE is low relative to the historical average, with the recent PE 81.0% lower than the historical average PE across our data set for Enanta Pharma. Looking at the recent ENTA PE on 3/11/2024 based on TTM EPS, we calculate the ratio at 188.5. Based on ENTA's history, that recent PE is elevated relative to the historical average, with the recent PE 682.2% higher than the historical average PE across our Enanta Pharma data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ENTA or any other given stock, valuation analysis for ENTA can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Enanta Pharma PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for ENTA. Thanks for visiting, and the next time you need to research ENTA PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: ETFs Holding BLOX, PDSB market cap history, CSGS Dividend History.

 

ENTA PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.